Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Tolfenamic Acid
100%
Malignant Neoplasm
78%
Pancreas Cancer
52%
Colorectal Carcinoma
32%
Transcription Factors
31%
Curcumin
31%
Survivin
26%
Rat
26%
Immunotherapy
25%
Transcription Factor Sp1
22%
Alzheimer's Disease
22%
Carcinogenesis
21%
Clinical Trial
20%
Neoplasm
20%
Diseases
18%
Colon Carcinoma
18%
Chemotherapy Regimens
17%
Tumor Growth
16%
Cancer Growth
16%
Nanoparticle
15%
Non-Steroidal Anti-Inflammatory Drug
15%
Ovary Cancer
13%
Preclinical Study
12%
Digestive System Cancer
11%
Reactive Oxygen Metabolite
11%
Vincristine
10%
Liver Cell Carcinoma
10%
Neuroblastoma
9%
Cell Viability
9%
Ewing Sarcoma
9%
Medulloblastoma
9%
Prostate Cancer
9%
Diazepam
9%
microRNA
9%
Liver Cancer
8%
Ethanol
8%
Drug Resistance
7%
Amyloid Protein
7%
Biological Marker
7%
Nerve Degeneration
7%
Amyloid Precursor Protein
7%
Western Blot
6%
Investigational Agent
6%
Cytokine
6%
Lung Cancer
6%
Bioavailability
6%
Lead Poisoning
6%
Flow Cytometry
6%
Therapeutic Effect
5%
Neurotoxicity
5%
Keyphrases
Tolfenamic Acid
50%
Specificity Protein 1
25%
Transcription Factor
22%
Colorectal Cancer
20%
Pancreatic Cancer
18%
Curcumin
18%
Pancreatic Cancer Cells
16%
Reactive Oxygen Species
11%
Survivin
11%
Chemotherapy
11%
Apoptosis Induction
11%
DNA Binding
10%
Ewing Sarcoma
9%
Clinical Trials
9%
Anticancer Activity
9%
Alzheimer's Disease
9%
Cancer Cell Growth
9%
Pancreatic Cancer Treatment
9%
Neuroblastoma Cells
9%
Alzheime's Disease
9%
Sarcoma Cells
9%
Mechanism of Action
8%
Nanoparticles
8%
Malignancy
8%
Therapeutic Potential
7%
Cell Viability
7%
United States
7%
Tumor Growth
7%
Drug Resistance
7%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7%
In Cancer
6%
Cancer Mortality
6%
Therapeutic Effect
6%
Cell Proliferation
6%
Antiproliferative Effect
6%
Neuroblastoma
6%
Transcription Factor Sp1
6%
Metastasis
6%
Acid Activation
6%
Cell Tumor
6%
Chemopreventive
5%
Cell Growth
5%
Hippocampus
5%
Cerebellum
5%
Hepatocellular Carcinoma
5%
Risk Factors
5%
Resistance to Therapy
5%
Epigenetics
5%
Acetylcholinesterase Activity
5%
T Cells
5%
Medicine and Dentistry
Pancreas Cancer
28%
Immunotherapy
25%
Cancer
15%
Malignant Neoplasm
15%
Gastrointestinal Cancer
13%
Clinical Trial
12%
Chemotherapy
10%
Hepatocellular Carcinoma
10%
Personalized Medicine
9%
Ovarian Cancer
9%
Cancer Cell
9%
Diseases
9%
Maturity Onset Diabetes of the Young
9%
Colon Carcinoma
9%
Health Disparity
8%
Survival Rate
7%
Colorectal Carcinoma
6%
Cancer Therapy
6%
Primary Tumor
6%
Cancer Immunotherapy
6%
Genetics
6%
T Cell
6%
Drug Resistance
5%
Tumor
5%
Liver Cancer
5%
Angiogenesis
5%